Exagamglogene autotemcel for treating severe sickle cell disease in people 12 years and over

Final draft guidance

Final draft guidance (PDF 546 KB)

Committee papers (PDF 6.64 MB)

Public committee slides (PDF 1.36 MB)

Public committee slides (PDF 453 KB)

Equality impact assessment (downloadable version) (PDF 175 KB)

Draft guidance

Draft guidance (PDF version) (PDF 489 KB)

Draft guidance (online commenting)

Committee papers (PDF 12.84 MB)

Public committee slides (PDF 691 KB)

Final scope (PDF 198 KB)

Final stakeholder list (PDF 164 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 614 KB)